John H Baird

17PUBLICATIONS
108CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Dec 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.

Hrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird

|Oct 08, 2025
Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration.

Lei Gao, Avyakta Kallam, Geoffrey Shouse

|Aug 20, 2025
Outpatient Brexucabtagene Autoleucel in B-Cell Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma.

Tamer Othman, John H Baird, Yan Wang

|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR.

Kitsada Wudhikarn, Megan M Herr, Min Chen

|Apr 15, 2025
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments.

Fateeha Furqan, Kwang W Ahn, Manmeet Kaur

|Jan 08, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.

Yi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton

Pageof 3

Frequent Collaborators

6 joint publications

Lihua E Budde

5 joint publications

David Miklos

5 joint publications

Alex Herrara

4 joint publications

Geoffrey Shouse